Medistim ASAOSL: MEDI

MEDI: Record first-half growth driven by Americas, product mix, and margin expansion

· Issued by Medistim ASA

Second quarter and first half 2025 saw record sales and profit growth, led by strong performance in the Americas and Asia Pacific, improved gross margins, and a robust product mix. Outlook is positive with expected benefits from new software launches and price increases.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Medistim ASA on 6ix

In the deck

Story so far

Earlier from Medistim

Later from Medistim

All Medistim news releases